News related to Remicade (Infliximab) and/or conditions it is approved for
Inflectra Approved as 'Biosimilar' to Remicade
Source: MedicineNet Psoriasis Specialty [2016.04.07]
Title: Inflectra Approved as 'Biosimilar' to Remicade
Category: Health News
Created: 4/6/2016 12:00:00 AM
Last Editorial Review: 4/7/2016 12:00:00 AM
FDA approves Inflectra, a biosimilar to Remicade
Source: Arthritis / Rheumatology News From Medical News Today [2016.04.06]
The U.S. Food and Drug Administration has approved Inflectra (infliximab-dyyb) for multiple indications. Inflectra is administered by intravenous infusion.
Remicade Phase 3 data show long-term psoriasis response
Source: The Doctors Lounge - Dermatology
Findings from two Phase 3 studies show high-level, sustained response with maintenance therapy.